Free Trial

Zentek (CVE:ZEN) Stock Price Passes Below 200-Day Moving Average - What's Next?

Zentek logo with Medical background

Key Points

  • Zentek Ltd. shares fell below their 200-day moving average during trading on Wednesday, with the stock last at C$1.16, down from a high of C$1.65.
  • The company has a market capitalization of C$119.17 million and a negative PE ratio, indicating significant financial challenges.
  • Zentek specializes in the research and development of graphene and related nanomaterials, producing products like antimicrobial coatings and personal protective equipment.
  • Need Better Tools to Track Zentek? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Shares of Zentek Ltd. (CVE:ZEN - Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$1.65 and traded as low as C$1.15. Zentek shares last traded at C$1.16, with a volume of 50,338 shares changing hands.

Zentek Trading Up 0.9%

The firm has a market capitalization of C$119.17 million, a PE ratio of -10.95 and a beta of 0.77. The company has a quick ratio of 7.59, a current ratio of 2.06 and a debt-to-equity ratio of 4.97. The stock's fifty day simple moving average is C$1.58 and its 200 day simple moving average is C$1.65.

Zentek Company Profile

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Zentek Right Now?

Before you consider Zentek, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.

While Zentek currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines